API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-litigation-for-bictegravir-sodium-emtricitabine-and-tenofovir-alafenamide-fumarate-tablets-80375.pdf
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-litigation-for-emtricitabine-and-tenofovir-alafenamide-fumarate-tablets-96673.pdf
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-of-odefsey-208351-emtricitabine-rilpivirine-hydrochloride-and-tenofovir-alafenamide-fumarate-tablets-1578398200.pdf
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-of-descovy-208215-emtricitabine-and-tenofovir-alafenamide-fumarate-tablets-1578411210.pdf
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-of-vemlidy-208464-tenofovir-alafenamide-fumarate-tablets-1578412337.pdf
http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Summary_for_the_public/human/004449/WC500250891.pdf